Aptamer Group PLC banner

Intrinsic Value

Is APTA undervalued or overvalued?

See the intrinsic value estimate for Aptamer Group PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

APTA Intrinsic Value
LOCKED
Unlock
Today vs. history

APTA looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with APTA’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor APTA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price 0.31
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to APTA

Fundamental Analysis

What Aptamer Group Does

Biotechnology Health Care

Aptamer Group PLC develops aptamers, which are short synthetic molecules that can bind to a target in a very specific way, much like an antibody does. The company sells aptamer discovery and development services to life science, diagnostic, and pharmaceutical customers who need custom binding molecules for tests, research tools, or therapeutic programs.

Headquarters
United Kingdom UK
Employees
30
IPO date
Dec 22, 2021
Read the full company overview
View Company Overview
Financials

Revenue & Expenses Breakdown
Aptamer Group PLC

Efficiency

Earnings Waterfall
Aptamer Group PLC

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one APTA stock?

The intrinsic value for Aptamer Group PLC (APTA) under the Base Case is hidden GBX.

Is APTA stock undervalued or overvalued?

Compared with the current market price of 0.31 GBX, the stock appears hidden.

Back to Top